An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.
Ann I ScherCatherine M BerjohnCelia ByrneRhonda E ColomboChristopher J ColomboMargaret Sanchez EdwardsEvan C EwersAnuradha GanesanMilissa JonesDerek T LarsonDaniel LibratyDavid A LindholmCristian S MadarCarlos J MaldonadoRyan C MavesKatrin MendeStephanie A RichardJulia S RozmanJennifer RusieckiAlfred SmithMark SimonsDavid R TribbleBrian K AganTimothy H BurgessSimon D Pollettnull nullPublished in: Open forum infectious diseases (2022)
Vaccine side effects sufficient to prevent usual activities were more common after the second than first dose and varied by vaccine type. First dose side effects were more likely in those with a history of COVID-19-particularly if that prior illness was severe or associated with inpatient care. These findings may assist clinicians and patients by providing a real-world evaluation of the likelihood of experiencing impactful postvaccine symptoms.